Search Results - "Frey, Molly A."

Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease by Modak, Mallika, Frey, Molly A, Yi, Sijia, Liu, Yugang, Scott, Evan A

“…Cardiovascular disease (CVD) is a leading cause of global mortality, accounting for pathologies that are primarily of atherosclerotic origin and driven by…”
Get full text

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability by Burke, Jacqueline A., Zhang, Xiaomin, Bobbala, Sharan, Frey, Molly A., Bohorquez Fuentes, Carolina, Freire Haddad, Helena, Allen, Sean D., Richardson, Reese A. K., Ameer, Guillermo A., Scott, Evan A.

“…Standard oral rapamycin (that is, Rapamune) administration is plagued by poor bioavailability and broad biodistribution. Thus, this pleotropic mammalian target…”
Get full text

209.8: Subcutaneous Nanotherapy Repurposes the Immunosuppressive Mechanism of Rapamycin to Enhance Allogeneic Islet Graft Viability by Burke, Jacqueline, Zhang, Xiaoming, Frey, Molly A., Reddy Bobbala, Sharan Kumar, Richardson, Reese AK, Allen, Sean D., Liu, Yu-Gang, Bohorquez Fuentes, Carolina, Haddad, Helena Freire, Ameer, Guillermo A., Scott, Evan A.

Get full text

The Combination of Morphology and Surface Chemistry Defines the Immunological Identity of Nanocarriers in Human Blood by Vincent, Michael P., Karabin, Nicholas B., Allen, Sean D., Bobbala, Sharan, Frey, Molly A., Yi, Sijia, Yang, Yufan, Scott, Evan A.

“…Upon exposure to blood, a corona of proteins adsorbs to nanocarrier surfaces to confer a biological identity that interfaces with the immune system. While the…”
Get full text